Country: Израел
Језик: Енглески
Извор: Ministry of Health
CLOPIDOGREL AS BISULFATE
TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL
B01AC04
TABLETS
CLOPIDOGREL AS BISULFATE 75 MG
PER OS
Required
TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL
CLOPIDOGREL
CLOPIDOGREL
Prevention of atherotrobmotic eventsClopidogrel is indicated in :• Adult Patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease.• Adult Patients suffering from Acute Coronary Syndrome- Non-ST segment elevation acute coronary syndrome (unstable angina/non-Q-wave myocardial infarction (MI)), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (ASA). - ST segment elevation acute myocardial infarction, in combination with ASA in medically treated patients eligible for thrombolytic therapyPrevention of atherotrobmotic and thromboembolic events in atrial fibrillation: In adult patients with atrial fibrillation who have at least one risk factor for vascular events, are not suitable for the treatment with Vitamin K antagonists (VKA) Anti-Thrombin or Anti Factor Xa, and who have a low bleeding risk, clopid
2013-10-06
PATIENT LEAFLET IN ACCORDANCE WITH THE PHARMACISTS’ REGULATIONS (PREPARATIONS) – 1986 The medicine is dispensed with a doctor's prescription only CLOPIDOGREL TEVA TABLETS Composition: Each tablet contains: Clopidogrel (as bisulfate) 75 mg For information regarding inactive ingredients and allergens in this medicine, see section 2 under “Important information about some ingredients of the medicine” and section 6 - “Additional information”. READ THE ENTIRE LEAFLET CAREFULLY BEFORE USING THE MEDICINE. This leaflet contains concise information about the medicine. If you have additional questions, refer to the doctor or the pharmacist. This medicine has been prescribed for you. Do not pass it on to others. It may harm them even if it seems to you that their medical condition is similar. 1. WHAT IS THE MEDICINE INTENDED FOR? The medicine is used for the prevention of atherothrombotic vascular events (heart attacks, cerebral stroke or vascular death) in patients with atherosclerosis who have had a myocardial infarction or ischemic cerebrovascular event or who have a peripheral arterial disease, and in patients with unstable angina pectoris, including patients undergoing catheterization with stent implantation who are being treated with aspirin. The medicine is used to prevent atherothrombotic and thromboembolic events (heart attacks, cerebral strokes, embolisms or vascular death) in combination with aspirin, in patients suffering from atrial fibrillation-type arrhythmia, who are not suitable for treatment with anticoagulants of the vitamin K antagonist type such as warfarin (Coumadin), antithrombin or anti- factor Xa. THERAPEUTIC CLASS: Platelet aggregation inhibitors, of the thienopyridine group. 2. BEFORE USING THE MEDICINE DO NOT USE THIS MEDICINE IF: • You are sensitive (allergic) to clopidogrel or to any of the additional ingredients that the medicine contains (see section 6). • You are suffering from a medical condition which is currently causing bleeding, such as: stomach or duodenal ulcer, bleedi Прочитајте комплетан документ